Hanne Leth Hillman

Presidente presso The Danish Investor Relations Society

59 anni

Health Technology

Transportation

Finance

Posizioni attive di Hanne Leth Hillman

Società	Posizione	Inizio	Fine
The Danish Investor Relations Society	Presidente	-	-
The Danish Investor Relations Society	Direttore/Membro del Consiglio	-	-
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Direttore Finanziario/CFO	01/05/2017	-

Società	Posizione	Inizio	Fine
BRAIN+ A/S	Direttore/Membro del Consiglio	01/05/2021	01/01/2024
	Direttore Finanziario/CFO	01/09/2022	01/01/2024
	Independent Dir/Board Member	01/05/2021	01/09/2022
ZEALAND PHARMA A/S	Contatto Relazioni con gli Investitori	01/01/2011	01/10/2016
ZEALAND PHARMA A/S	Public Communications Contact	01/01/2011	01/10/2016
Gudme Raaschou Bank A/S	Analyst-Equity	05/11/2004	05/11/2004
NTG NORDIC TRANSPORT GROUP A/S	Contatto Relazioni con gli Investitori	-	-
NTG NORDIC TRANSPORT GROUP A/S	Public Communications Contact	28/08/2009	-

University of Aarhus

Masters Business Admin

Distribuzione geografica

Danimarca

Posizioni

Investor Relations Contact	2
Public Communications Contact	2
Director/Board Member	2

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	3
NTG NORDIC TRANSPORT GROUP A/S	Transportation
ZEALAND PHARMA A/S	Health Technology
BRAIN+ A/S	Technology Services

Aziende private	3
Gudme Raaschou Bank A/S	Finance
The Danish Investor Relations Society
Nanovi Radiotherapy A/S Nanovi Radiotherapy A/S Pharmaceuticals: MajorHealth Technology Nanovi Radiotherapy A/S provides radiotherapy related products for the treatment of cancer. Its product BioXmark is a liquid ready-to-insert fiducial marker, which once inserted into soft tissue forms a semi-solid gel. The firm's platform provides an opportunity to encapsulate chemotherapeutics within the gel. The company was founded by Thomas Lars Andresen and Morten Albrechtsen in 2012 and is headquartered in Kongens Lyngby, Denmark.	Health Technology